Epigenomics AG / Key word(s): Strategic Company Decision/ForecastEpigenomics AG terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook 06-March-2019 / 20:57 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely […]
Category: Insider Information
06. March 2019
Epigenomics AG terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook
Read more
23. October 2018
Epigenomics AG successfully completes capital increase; gross proceeds of EUR 22.3 million
Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase; gross proceeds of EUR 22.3 million 23-Oct-2018 / 21:01 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of […]
16. October 2018
Epigenomics AG: Epigenomics AG sets subscription price at EUR 1.86 per new share
Epigenomics AG / Key word(s): Corporate ActionEpigenomics AG: Epigenomics AG sets subscription price at EUR 1.86 per new share 16-Oct-2018 / 10:17 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content […]
03. October 2018
Epigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase
Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase 03-Oct-2018 / 17:05 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service […]
09. June 2018
Epigenomics AG: Centers for Medicare & Medicaid Services publish preliminary rate of $192 for Epigenomics’ colorectal cancer screening test Epi proColon(R)
Epigenomics AG / Key word(s): MiscellaneousEpigenomics AG: Centers for Medicare & Medicaid Services publish preliminary rate of $192 for Epigenomics’ colorectal cancer screening test Epi proColon(R) 09-Jun-2018 / 12:20 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The […]
30. May 2018
Epigenomics AG: American Cancer Society published its updated colorectal cancer screening guidelines
Epigenomics AG / Key word(s): Scientific publicationEpigenomics AG: American Cancer Society published its updated colorectal cancer screening guidelines 30-May-2018 / 20:55 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of […]